Clinical trials

  • CERTOLIZUMAB PEGOL for Systemic lupus erythematosus (moderate or severe activity)
  • BI 3820768 for Advanced relapsed or refractory ovarian cancer|Advanced relapsed or refractory endometrial cancer|Advanced relapsed or refractory germ cell tumours
  • Mesothelin x CD47 bispecific antibody for Mesothelin-expressing solid tumours
  • SACCHAROMYCES BOULARDII CNCM I-745 LYOPHILIZED for Irritable bowel syndrome (non-constipated)
  • LIDOCAINE HYDROCHLORIDE MONOHYDRATE for Postoperative critical care
  • LEVOLEUCOVORIN for Resected pancreatic adenocarcinoma
  • Tocilizumab for Psoriatic arthritis | Rheumatoid arthritis
  • PSILOCYBINE for Depressive disorder comorbid with cancer
  • DWJ155 (radiolabelled with gallium-68) for Breast cancer|Non-small cell lung cancer
  • IBUZATRELVIR for COVID-19
  • TRONTINEMAB for Alzheimer's disease | Mild cognitive impairment (MCI) | Mild dementia due to Alzheimer's disease
  • Allopurinol for Hyperuricemia | Hypertension | Ischaemic stroke | Intracerebral haemorrhage | Transient ischaemic attack | Heart failure | Peripheral arterial disease | Atrial fibrillation | Diabetes mellitus